United Therapeutics Corporation (UTHR) earnings
UTHR earnings moved a median of +0.55% by the close. Quarterly and annual UTHR reports and results, each read against the price at its own news timestamp. Back to the UTHR overview →
30 measured UTHR earnings events.
Where these UTHR earnings landedvs 30 measured UTHR earnings reactions
| Middle 50% of UTHR earnings reactions | -2.10% to +2.77% |
|---|---|
| Median reaction (to close) | +0.55% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 UTHR earnings events with a measured close landed between -2.10% and +2.77%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q UNITED THERAPEUTICS Corp For: Jun 30 | SEC filing · Form 10-Q | -0.06% | +2.77% | |
| United Therapeutics Corporation Reports Second Quarter 2026 Financial Results | Press release | -0.06% | +2.77% | |
| United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026 | Press release | -0.24% | -1.64% | |
| Form 10-Q UNITED THERAPEUTICS Corp For: Mar 31 | SEC filing · Form 10-Q | +3.05% | +1.24% | |
| United Therapeutics Corporation Reports First Quarter 2026 Financial Results | Press release | +3.05% | +1.24% | |
| United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026 | Press release | +0.34% | +0.11% | |
| Form 10-K UNITED THERAPEUTICS Corp For: Dec 31 | SEC filing · Form 10-K | +3.92% | +11.48% | |
| Form 10-Q UNITED THERAPEUTICS Corp For: Sep 30 | SEC filing · Form 10-Q | +7.31% | +9.65% | |
| United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results | Press release | +7.31% | +9.65% | |
| United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025 | Press release | +0.63% | -0.28% | |
| Form 10-Q UNITED THERAPEUTICS Corp For: Jun 30 | SEC filing · Form 10-Q | +0.60% | -5.29% | |
| United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results | Press release | +0.60% | -5.29% | |
| United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025 | Press release | +0.58% | +0.99% | |
| Form 10-Q UNITED THERAPEUTICS Corp For: Mar 31 | SEC filing · Form 10-Q | -0.95% | -4.42% | |
| United Therapeutics Corporation Reports First Quarter 2025 Financial Results | Press release | -0.95% | -4.42% | |
| United Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025 | Press release | -0.01% | -0.28% | |
| Form 10-K UNITED THERAPEUTICS Corp For: Dec 31 | SEC filing · Form 10-K | -3.75% | -7.17% | |
| Form 10-Q UNITED THERAPEUTICS Corp For: Sep 30 | SEC filing · Form 10-Q | +0.73% | +1.33% | |
| United Therapeutics Corporation Reports Third Quarter 2024 Financial Results | Press release | +0.73% | +1.33% | |
| United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024 | Press release | -0.08% | -4.58% | |
| Form 10-Q UNITED THERAPEUTICS Corp For: Jun 30 | SEC filing · Form 10-Q | -1.16% | -2.26% | |
| United Therapeutics Corporation Reports Second Quarter 2024 Financial Results | Press release | -1.16% | -2.26% | |
| United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024 | Press release | -0.12% | -1.49% | |
| Form 10-Q UNITED THERAPEUTICS Corp For: Mar 31 | SEC filing · Form 10-Q | -1.39% | +5.00% | |
| United Therapeutics Corporation Reports First Quarter 2024 Financial Results | Press release | -1.39% | +5.00% | |
| United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 | Press release | +0.23% | +1.45% | |
| Form 10-K UNITED THERAPEUTICS Corp For: Dec 31 | SEC filing · Form 10-K | -0.18% | -0.24% | |
| Form 10-Q UNITED THERAPEUTICS Corp For: Sep 30 | SEC filing · Form 10-Q | +2.04% | +5.85% | |
| United Therapeutics Corporation Reports Third Quarter 2023 Financial Results | Press release | +2.04% | +5.85% | |
| United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023 | Press release | +1.08% | -0.87% |
Keep exploring
More UTHR: analyst actions → · SEC filings → · UTHR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Recro Pharma, Inc. (REPH) | 965 | 0.00% | 43% |
| Athenex, Inc. (ATNX) | 964 | -0.43% | 41% |
| Natera, Inc. (NTRA) | 957 | +0.21% | 57% |
| Antares Pharma, Inc. (ATRS) | 951 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.